AM Investicijos - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-12-31
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,857,217 | 1,960,450 | 2,942,475 | 2,416,622 | 1,236,324 | 1,233,308 | 788,194 | 1,715,600 |
| Profit before tax | 284,759 | 265,949 | 364,628 | 324,797 | 89,382 | 35,802 | 173,991 | 231,575 |
| Net profit | 241,439 | 225,363 | 309,818 | 275,477 | 83,300 | 29,202 | 189,699 | 222,396 |
| Equity | 733,311 | 958,674 | 1,268,492 | 1,543,969 | 1,627,269 | 1,656,471 | 1,132,241 | 1,104,637 |
| Liabilities | 366,387 | 516,330 | 307,512 | 402,372 | 82,964 | 111,000 | 34,914 | 207,091 |
| Non-current assets | 282,291 | 273,040 | 313,934 | 669,687 | 636,819 | 595,799 | 508,062 | 656,482 |
| Current assets | 816,215 | 1,200,520 | 1,261,214 | 1,275,501 | 1,072,807 | 1,171,672 | 606,488 | 557,693 |
| Total assets | 1,098,506 | 1,473,560 | 1,575,148 | 1,945,188 | 1,709,626 | 1,767,471 | 1,114,550 | 1,214,175 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 137,336 | 149,246 | 402,721 |
| Social insurance contributions | - | - | - | - | - | 21,996 | 26,538 | 30,838 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.1% | +5.6% | +50.1% | -17.9% | -48.8% | -0.2% | -36.1% | +117.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.0% | 15.3% | 19.7% | 14.2% | 4.9% | 1.7% | 17.0% | 18.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 32.9% | 23.5% | 24.4% | 17.8% | 5.1% | 1.8% | 16.8% | 20.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 13.0% | 11.5% | 10.5% | 11.4% | 6.7% | 2.4% | 24.1% | 13.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 15.3% | 13.6% | 12.4% | 13.4% | 7.2% | 2.9% | 22.1% | 13.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.5 | 0.2 | 0.3 | 0.1 | 0.1 | 0.0 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 371,443 | 392,090 | 588,495 | 483,324 | 178,745 | 170,111 | 101,702 | 141,008 |
Sales revenue
Consolidated AM Investicijos finance
|
EUR
|
2022
From: 2022-01-01
To: 2023-01-31
|
2023
From: 2023-02-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 16,719,039 | 24,376,125 | 29,502,147 | 25,995,230 |
| Profit before tax | -129,870 | 1,190,656 | 1,077,452 | 1,102,353 |
| Net profit | -128,666 | 996,042 | 870,615 | 893,794 |
| Equity | 3,031,574 | 4,032,616 | 4,178,976 | 4,839,110 |
| Liabilities | 4,344,114 | 4,712,632 | 4,415,917 | 4,325,091 |
| Non-current assets | 1,410,863 | 1,049,804 | 1,026,896 | 1,080,681 |
| Current assets | 5,964,047 | 7,695,444 | 7,515,392 | 8,030,558 |
| Total assets | 7,374,910 | 8,745,248 | 8,542,288 | 9,111,239 |
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
AM Investicijos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-10 | 2025-02-10 | 0.01 |
| 2025-01-16 | 2025-02-06 | 0.01 |
| 2025-01-02 | 2025-01-08 | 0.06 |
| 2024-12-22 | 2024-12-31 | 0.06 |
| 2024-12-17 | 2024-12-20 | 0.06 |
| 2024-01-16 | 2024-01-18 | 8.96 |
AM Investicijos - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
AM Investicijos, UAB is a Private Limited Liability Company (code 303218427) engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €1.72M and net profit of €222.4K, corresponding to a profit margin of 13.0%. Revenue increased by 117.7% year on year, after €788.2K in 2024, and was also 39.1% above the 2023 level of €1.23M. Net profit followed a strong upward path over the period, rising from €29.2K in 2023 to €189.7K in 2024 and €222.4K in 2025. The 2025 balance sheet showed total assets of €1.21M, equity of €1.10M and liabilities of €207.1K. The equity ratio stood at 91.0%, while debt-to-equity was 0.19, indicating a conservative capital structure. Return on equity was 20.1% and return on assets 18.3% in 2025. Asset turnover was 1.41x. With revenue per employee of €143.0K and profit per employee of €18.5K, the company showed solid operating productivity in the latest financial year.